La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Glyceraldehyde-3-phosphate dehydrogenase (phosphorylating)2
Makoto Naoi1
Glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) Sauf Makoto Naoi" 1
Makoto Naoi Sauf Glyceraldehyde-3-phosphate dehydrogenase (phosphorylating)" 0
Glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) Et Makoto Naoi 1
Glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) Ou Makoto Naoi 2
Corpus1799
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 1.
Ident.Authors (with country if any)Title
000A50 Wakako Maruyama [Japon] ; Yukihiro Akao [Japon] ; Moussa B. H. Youdim [Israël] ; Bruce A. Davis [Canada] ; Makoto Naoi [Japon]Transfection-enforced Bcl-2 overexpression and an anti-Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022